Statins may reduce androgen receptor expression and activity which could lead to reduced prostate cancer cell proliferation and increased apoptosis [4, 5] and a reduction in prostate specific antigen (PSA) release by such cells [4]. The gene discussed is KLK3; the disease is prostate carcinoma.